An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Avelumab related Merkel Cell Carcinoma: biological plausibility explained — Research Summary — detailed background and analysis.
Reference: National Institutes of Health (NIH)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.